Status:
COMPLETED
An Observational Study Evaluating the Safety of Topiramate for the Prevention of Migraine
Lead Sponsor:
Janssen Cilag Pharmaceutica S.A.C.I., Greece
Conditions:
Migraine Disorders
Eligibility:
All Genders
18+ years
Brief Summary
A 6-month, observational, post authorization safety study for the collection and evaluation of additional safety data on topiramate as a prophylactic treatment for migraines in adult patients. Accordi...
Detailed Description
Previous studies have shown that topiramate is effective in preventing migraine headaches. This is a 6-month observational study to evaluate additional safety data of topiramate in the prevention of m...
Eligibility Criteria
Inclusion
- Patients who meet the IHS (International Headache Society) diagnostic criteria for migraine
- Patients who satisfy the migraine prophylactic medication criteria
Exclusion
- Ineligible patient according to the marketed Summary of Product Characteristics of topiramate
- Patient with hypersensitivity to topiramate or to some of its components
Key Trial Info
Start Date :
March 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2007
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT00297336
Start Date
March 1 2005
End Date
February 1 2007
Last Update
April 27 2010
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.